Advances and Applications in Catalysis for Pharmaceuticals
A special issue of Catalysts (ISSN 2073-4344). This special issue belongs to the section "Catalysis in Organic and Polymer Chemistry".
Deadline for manuscript submissions: closed (10 November 2022) | Viewed by 351
Special Issue Editor
Interests: high-performance liquid chromatography; natural product chemistry; medicinal and pharmaceutical chemistry; heterogeneous catalysis; mesoporous materials; natural product isolation; column chromatography chemical organic synthesis; synthetic chemistry
Special Issue Information
Dear Colleagues,
The successes of catalysis in the creation of modern drugs are beyond question. For example, in the syntheses of statins or paclitaxel, these have been worldwide challenges for synthetic chemists for decades. This Special Issue is devoted to advances in catalytic synthesis of new drugs or, equally, to new approaches to important drug compounds. Modern pharmaceuticals are usually chiral substances, and the asymmetric synthesis of such compounds or their key precursors is the special interest of this Special Issue.
Pharmaceuticals need to be synthesized in quantities large enough to meet the needs of health care while, at the same time, classical syntheses of complex compounds are accompanied by the generation of huge amounts of waste per unit of the target product. Therefore, the second special interest of this Special Issue is the work related to increasing the atomic efficiency of syntheses, increasing the yields, as well as obtaining complex scaffolds in a minimum number of stages.
Dr. Vladislav Fomenko
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Catalysts is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- catalytic synthesis
- pharmaceuticals
- asymmetric catalysis
- induced chirality
- atomic efficiency
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
